About CathWorks Ltd
CathWorks is a global leader in digital health innovations focused on transforming how cardiovascular disease is diagnosed and treated. The company's flagship product, the CathWorks FFRangio System, combines artificial intelligence and advanced computational science to obtain physiologic information from routine angiograms, eliminating the need for drug stimulation and invasive pressure wires. The system provides physicians with quick and reliable intraprocedural FFRangio values for the entire coronary tree, enabling comprehensive physiologic assessment across multiple vessels. The FFRangio System delivers real-time FFRangio values at every point on the coronary tree, simulated pullback curves to differentiate functional patterns of coronary artery disease, and integrated sizing tools for non-invasive lesion measurements. The technology has been adopted by major health systems across the United States and internationally, with institutions like Lenox Hill Hospital performing over 1,000 cases. CathWorks is now part of Medtronic, expanding its reach to improve patient outcomes globally. The company is dedicated to partnering with physicians to improve patient health through innovative cardiovascular diagnostic solutions.
Mission & Story
Mission
We are dedicated to partnering with physicians to improve the health of patients by transforming how cardiovascular disease is diagnosed and treated.
Founding Story
CathWorks was founded by Ran Kornowski, MD, FESC, Guy Lavi, and Ifat Lavi, PhD to develop AI-powered solutions for cardiovascular disease diagnosis and treatment.
Clinical Focus
Medical conditions and clinical areas addressed by CathWorks Ltd.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired by Medtronic (2025), ALL-RISE Global Study completed enrollment of 1,927 patients (2025), PROVISION Trial results presented at ACC.26 (2025), EU-MDR approval received (2024), 4th generation FFRangio System launched (2021), Lenox Hill Hospital reached 1,000 FFRangio cases milestone
Awards & Recognition
Finalist for Best Technology Company Leadership Team at 2025 Octane High Tech Awards
Key Partnerships
Social & Media
Follow on
Latest Updates
Recent Posts
3mo ago
Late-Breaking Clinical Trial Presentation of the First-Ever US Cohort of Over 4,000 CathWorks FFRangio Patients Demonstrates Similar Clinical Outcomes to Invasive Pressure Wire-Guided PCI through 2 Years
4mo ago
Role of CathWorks FFRangio for the Assessment of Coronary Artery Disease Now Reinforced by SCAI Expert Opinion
5mo ago
As Featured in Cardiac Wire: CathWorks FFRangio Goes Beyond Physiology
7mo ago
CathWorks FFRangio: Proven Outcomes without Compromise or Complications (TCT 2025, San Francisco, CA)
8mo ago
Company Details
- Founded
- 2013
- Headquarters
- Newport Beach, CA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.